Physician profile
Audrey Williamson
NPI 1235696105
$1,116.79
in general payments reported to CMS, 2019-2025
10 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.42 · 2022: $112 · 2023: $397 · 2024: $248 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $324.13 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $203.93 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $199.58 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $122.66 | 2023 | Onyx Frontier |
| Chiesi USA, INC. | $81.89 | 2024-2025 | Kengreal |
| Pfizer INC. | $78.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $39.87 | 2022 | |
| Amgen INC. | $27.58 | 2023 | Repatha |
| Heartflow, INC. | $25.42 | 2024 | |
| Impulse Dynamics (USA) INC. | $13.31 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.